Organizing Pneumonia and Idiopathic Pulmonary Fibrosis Diagnosis and Management
Introduction to Organizing Pneumonia and Idiopathic Pulmonary Fibrosis
- The American Thoracic Society (ATS) and European Respiratory Society (ERS) consensus explicitly excludes idiopathic bronchiolitis obliterans organizing pneumonia (BOOP) from the idiopathic pulmonary fibrosis (IPF) category, classifying them as separate entities 1
Histopathologic Distinction
- IPF is defined by the usual interstitial pneumonia (UIP) pattern, characterized by heterogeneous, temporally varied fibrosis with fibroblastic foci, dense scarring, and honeycomb change in a patchy subpleural distribution 1, 4
- Organizing pneumonia shows buds of granulation tissue (fibroblasts and myofibroblasts in loose connective matrix) filling alveolar ducts and airspaces, representing a reversible process of intraalveolar organization 2, 3
Clinical Presentation
- COP presents subacutely (symptoms developing over less than 2-3 months) with flu-like illness including fever, cough, malaise, fatigue, and weight loss in 40% of patients 2, 3
- IPF presents insidiously with progressive dyspnea over months to years without fever or systemic inflammatory symptoms, and strongly favors males over 60 years with smoking history 6
Radiologic Features
- COP shows patchy bilateral airspace consolidation with peripheral/subpleural distribution, ground-glass opacities, and the characteristic "reversed halo sign" (atoll sign) 2, 3, 7
- IPF demonstrates basal and subpleural-predominant reticular abnormalities, traction bronchiectasis, and honeycombing defining the UIP pattern 4, 7
Treatment Response and Prognosis
- COP responds rapidly and completely to oral corticosteroids in the majority of patients, with dramatic clinical and radiographic improvement 2, 3, 7
- IPF shows no adequate response to corticosteroids or conventional immunosuppression, with no proven therapy improving survival or quality of life 1
- IPF has an estimated median survival less than 3 years 1
- COP has excellent long-term prognosis with complete recovery in most cases 3, 7
Management Algorithm
- For suspected organizing pneumonia, the American College of Chest Physicians recommends initiating oral corticosteroids after excluding infection and other causes, expecting rapid improvement within weeks, and monitoring for relapse after treatment cessation 2, 3, 7
- For suspected IPF, the American Thoracic Society recommends antifibrotic therapy (nintedanib or pirfenidone) as first-line treatment, considering lung transplantation for progressive deterioration, and avoiding corticosteroids as primary therapy 1, 6